UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review

Filippi, M; Preziosa, P; Barkhof, F; Chard, DT; De Stefano, N; Fox, RJ; Gasperini, C; ... Rocca, MA; + view all (2020) Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review. JAMA Neurology 10.1001/jamaneurol.2020.4689. (In press).

[thumbnail of Barkhof_Filippi - DIAGNOSIS OF PROGRESSIVE MULTIPLE SCLEROSIS FROM THE IMAGING PERSPECTIVE - JAMA Neurol-2004.R1_Manuscript_clean.pdf] Text
Barkhof_Filippi - DIAGNOSIS OF PROGRESSIVE MULTIPLE SCLEROSIS FROM THE IMAGING PERSPECTIVE - JAMA Neurol-2004.R1_Manuscript_clean.pdf - Accepted Version
Access restricted to UCL open access staff

Download (336kB)

Abstract

Importance: Although magnetic resonance imaging (MRI) is useful for monitoring disease dissemination in space and over time and excluding multiple sclerosis (MS) mimics, there has been less application of MRI to progressive MS, including diagnosing primary progressive (PP) MS and identifying patients with relapsing-remitting (RR) MS who are at risk of developing secondary progressive (SP) MS. This review addresses clinical application of MRI for both diagnosis and prognosis of progressive MS. Observations: Although nonspecific, some spinal cord imaging features (diffuse abnormalities and lesions involving gray matter [GM] and ≥2 white matter columns) are typical of PPMS. In patients with PPMS and those with relapse-onset MS, location of lesions in critical central nervous system regions (spinal cord, infratentorial regions, and GM) and MRI-detected high inflammatory activity in the first years after diagnosis are risk factors for long-term disability and future progressive disease course. These measures are evaluable in clinical practice. In patients with established MS, GM involvement and neurodegeneration are associated with accelerated clinical worsening. Subpial demyelination and slowly expanding lesions are novel indicators of progressive MS. Conclusions and Relevance: Diagnosis of PPMS is more challenging than diagnosis of RRMS. No qualitative clinical, immunological, histopathological, or neuroimaging features differentiate PPMS and SPMS; both are characterized by imaging findings reflecting neurodegeneration and are also impacted by aging and comorbidities. Unmet diagnostic needs include identification of MRI markers capable of distinguishing PPMS from RRMS and predicting the evolution of RRMS to SPMS. Integration of multiple parameters will likely be essential to achieve these aims.

Type: Article
Title: Diagnosis of Progressive Multiple Sclerosis From the Imaging Perspective: A Review
Location: United States
DOI: 10.1001/jamaneurol.2020.4689
Publisher version: https://doi.org/10.1001/jamaneurol.2020.4689
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Brain Repair and Rehabilitation
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neuroinflammation
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10118074
Downloads since deposit
76Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item